Keysight partners with NVIDIA on quantum-AI computing architecture
When InvestingPro’s Fair Value model identified Soleno Therapeutics (NASDAQ:SLNO) as significantly overvalued on July 31, 2025, it provided investors with a crucial early warning signal. The sophisticated valuation model, which combines multiple analytical approaches to determine a stock’s intrinsic value, suggested a substantial downside potential for the emerging biotech company. For investors seeking similar opportunities, our Most overvalued list continues to identify stocks trading above their fundamental value.
Soleno Therapeutics, a healthcare company focused on rare disease therapeutics, had been riding high on enthusiasm surrounding its VYKAT XR drug launch. Despite positive developments including strong Q2 earnings and numerous analyst upgrades, InvestingPro’s Fair Value analysis indicated the stock was trading well above its fundamental value at $86.48, projecting a potential downside of 36.15%.
The model’s accuracy was validated as SLNO’s stock price declined to $49.71 by mid-September, representing a 42.52% decrease. This movement aligned closely with the model’s projected fair value, demonstrating the effectiveness of InvestingPro’s analytical approach. The decline accelerated following reports of patient safety concerns, though multiple analysts maintained their positive ratings on the stock.
Recent developments have supported the initial valuation concerns. While the company reported Q2 revenue of $32.7 million and received several price target increases from major analysts, fundamental metrics including negative EBITDA of $184.3 million and EPS of -$3.97 suggested the previous valuation levels were unsustainable.
InvestingPro’s Fair Value methodology combines multiple valuation approaches, including discounted cash flow analysis, comparable company metrics, and market-based indicators. This comprehensive approach helps investors identify potential mispricings before they correct, as demonstrated in this case with Soleno Therapeutics.
The success of this Fair Value call highlights the importance of combining fundamental analysis with sophisticated valuation tools. InvestingPro offers investors access to these powerful analytical capabilities, along with real-time alerts and detailed financial metrics, helping them make more informed investment decisions. As markets continue to evolve, having access to professional-grade analytical tools becomes increasingly crucial for successful investing.